Ocular Therapeutix Inc’s filing revealed that its Officer PHILIP C. STRASSBURGER acquired Company’s shares for reported $0.13 million on Oct 16 ’24. In the deal valued at $10.23 per share,13,125 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Nayak Sanjay sold 1,832 shares, generating $16,525 in total proceeds. Upon selling the shares at $9.02, the Chief Strategy Officer now owns 176,194 shares.
Before that, Dugel Pravin sold 20,880 shares. Ocular Therapeutix Inc shares valued at $188,338 were divested by the insider at a price of $9.02 per share. As a result of the transaction, Dugel Pravin now holds 812,473 shares, worth roughly $8.61 million.
Scotiabank initiated its Ocular Therapeutix Inc [OCUL] rating to a Sector outperform in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who increased its forecast for the stock in mid June from “a Hold” to “a Buy”. BofA Securities started covering the stock on February 09, 2024. It rated OCUL as “a Buy”.
Price Performance Review of OCUL
On Tuesday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock fall -3.28% to $10.60. Over the last five days, the stock has gained 0.28%. Ocular Therapeutix Inc shares have risen nearly 137.67% since the year began. Nevertheless, the stocks have risen 403.56% over the past one year. While a 52-week high of $11.77 was reached on 10/28/24, a 52-week low of $2.02 was recorded on 01/19/24. SMA at 50 days reached $9.79, while 200 days put it at $7.95.
Levels Of Support And Resistance For OCUL Stock
The 24-hour chart illustrates a support level at 10.36, which if violated will result in even more drops to 10.11. On the upside, there is a resistance level at 10.95. A further resistance level may holdings at 11.29. The Relative Strength Index (RSI) on the 14-day chart is 51.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.31%. Stochastics %K at 55.91% indicates the stock is a holding.
How much short interest is there in Ocular Therapeutix Inc?
A steep rise in short interest was recorded in Ocular Therapeutix Inc stocks on 2024-10-15, dropping by -4.19 million shares to a total of 13.26 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 17.46 million shares. There was a decline of -31.62%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 21, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
